BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29031504)

  • 1. [Therapeutic targeting of Notch signaling in cancer].
    Brahmi M; Bally O; Eberst L; Cassier P
    Bull Cancer; 2017 Oct; 104(10):883-891. PubMed ID: 29031504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.
    Gao L; Yuan K; Ding W; Lin M
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):239-46. PubMed ID: 27650987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling: an emerging therapeutic target for cancer treatment.
    Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K
    Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling, gamma-secretase inhibitors, and cancer therapy.
    Shih IeM; Wang TL
    Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Notch and its oncogenic signaling crosstalk in breast cancer.
    Guo S; Liu M; Gonzalez-Perez RR
    Biochim Biophys Acta; 2011 Apr; 1815(2):197-213. PubMed ID: 21193018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting notch signaling pathway in cancer: clinical development advances and challenges.
    Takebe N; Nguyen D; Yang SX
    Pharmacol Ther; 2014 Feb; 141(2):140-9. PubMed ID: 24076266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling as a therapeutic target for acute lymphoblastic leukemia.
    Bellavia D; Palermo R; Felli MP; Screpanti I; Checquolo S
    Expert Opin Ther Targets; 2018 Apr; 22(4):331-342. PubMed ID: 29527929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Notch signaling for cancer therapeutic intervention.
    Shao H; Huang Q; Liu ZJ
    Adv Pharmacol; 2012; 65():191-234. PubMed ID: 22959027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
    Nefedova Y; Gabrilovich D
    Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOTCH signaling in lung diseases.
    Jiang J; Xiao K; Chen P
    Exp Lung Res; 2017; 43(4-5):217-228. PubMed ID: 28636457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision medicine for human cancers with Notch signaling dysregulation (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling in gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2007 Jan; 30(1):247-51. PubMed ID: 17143535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch signaling in serous ovarian cancer.
    Groeneweg JW; Foster R; Growdon WB; Verheijen RH; Rueda BR
    J Ovarian Res; 2014 Nov; 7():95. PubMed ID: 25366565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Notch as a Therapeutic Approach for Human Malignancies.
    Platonova N; Lesma E; Basile A; Bignotto M; Garavelli S; Palano MT; Moschini A; Neri A; Colombo M; Chiaramonte R
    Curr Pharm Des; 2017; 23(1):108-134. PubMed ID: 27719637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening compatible cell-based assay for interrogating activated notch signaling.
    Hancock MK; Kopp L; Bi K
    Assay Drug Dev Technol; 2009 Feb; 7(1):68-79. PubMed ID: 19382889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-associated microRNAs in cancer.
    Mo YY; Tang H; Miele L
    Curr Drug Targets; 2013 Sep; 14(10):1157-66. PubMed ID: 23834150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
    Kumar R; Juillerat-Jeanneret L; Golshayan D
    J Med Chem; 2016 Sep; 59(17):7719-37. PubMed ID: 27045975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Notch Receptors in Hematologic Malignancies.
    Gragnani L; Lorini S; Marri S; Zignego AL
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.